CEO Clips: Resverlogix (TSX: RVX) | The Future of Drug Development



Resverlogix Corp. (TSX: RVX) is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses and providing value-based health solutions to key partners.


The Company was founded in 2001 by Donald McCaffrey and Norman Wong. They’re a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses.


They provide novel science, clinical, and value-based health solutions to key stakeholders such as pharmaceutical, physician, and health payer groups.


For more information: https://b-tv.com/resverlogix-the-futu...

Subscribe to receive more investment opportunities videos: http://bit.ly/Subscribe2BTV

Check out more videos: BTV Business Television episodes: http://bit.ly/2UBerea

CEO Clips: http://bit.ly/2UTdumA

New Listing Alert: http://bit.ly/2W1o0ob#Resverlogix #RVX #RVX


SOURCE





Recent Posts

See All